MFBTD
ECYT

MB Financial Bank - Trust Department’s Endocyte, Inc. Common Stock ECYT Stock Holding History

MB Financial Bank - Trust Department’s Portfolio ECYT Stock Details ECYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-250
Closed -$1K – 647
2015
Q3 		$1K Hold
250
– – ﹤0.01% 623
2015
Q2 		$1K Hold
250
– – ﹤0.01% 610
2015
Q1 		$2K Buy
+250
New +$1.44K ﹤0.01% 412

Other funds holding ECYT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

MB Financial Bank - Trust Department's ECYT Position: Q4 2015 in Review

MB Financial Bank - Trust Department sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2015, closing a stake of 250 shares — an estimated $1K sold.

MB Financial Bank - Trust Department first reported a position in ECYT in Q1 2015 and held it in 3 quarters. The position peaked at $2K in Q1 2015. 102 funds tracked by Wall St. Rank hold ECYT as of Q4 2015.

  • MB Financial Bank - Trust Department reported no remaining Endocyte, Inc. Common Stock position as of Q4 2015 after selling out during the quarter.
  • MB Financial Bank - Trust Department sold 250 Endocyte, Inc. Common Stock shares in Q4 2015, an estimated $1K.
  • MB Financial Bank - Trust Department first reported a position in Endocyte, Inc. Common Stock in Q1 2015 and held it in 3 quarters.
  • MB Financial Bank - Trust Department's Endocyte, Inc. Common Stock position peaked at $2K in Q1 2015.
  • 102 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2015.

Based on MB Financial Bank - Trust Department's 13F filing for Q4 2015, filed 7 Jan 2016.